4//SEC Filing
Bellon Steven F. 4
Accession 0001562180-22-004545
CIK 0001822462other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 4:10 PM ET
Size
11.9 KB
Accession
0001562180-22-004545
Insider Transaction Report
Form 4
Bellon Steven F.
Chief Scientific Officer
Transactions
- Exercise/Conversion
Stock Options (Right to buy)
2022-05-25−675→ 0 totalExercise: $0.73Exp: 2028-01-30→ Common Stock (675 underlying) - Exercise/Conversion
Common Stock
2022-05-25$0.73/sh+675$493→ 116,382 total - Exercise/Conversion
Common Stock
2022-05-25$3.72/sh+3,717$13,827→ 120,099 total - Exercise/Conversion
Stock Options (Right to buy)
2022-05-25−3,717→ 5,574 totalExercise: $3.72Exp: 2029-02-13→ Common Stock (3,717 underlying)
Holdings
- 50,000(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]Shares held by the Steven F. Bellon 2021 Irrevocable Trust dated December 3, 2021, of which the Reporting Person's children are the trustees.
- [F2]The option vested at a rate of 6.25% of the underlying shares beginning on April 1, 2018 and thereafter on the first day of each calendar quarter until the option was fully vested.
- [F3]The option vested as to 25% of the underlying shares of common stock on January 30, 2020, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested.
Documents
Issuer
Foghorn Therapeutics Inc.
CIK 0001822462
Entity typeother
Related Parties
1- filerCIK 0001831749
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 4:10 PM ET
- Size
- 11.9 KB